A Study of LY2523355 in Participants With Breast Cancer

Clinical trial NCT01416389 · COMPLETED

Trial details

NCT number: NCT01416389
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2011-08-01
Primary completion: 2012-08-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.